Research Paper Volume 13, Issue 1 pp 351—363
ADRB1 was identified as a potential biomarker for breast cancer by the co-analysis of tumor mutational burden and immune infiltration
Figure 4. Functional enrichment analysis. (A) MF, BP, CC in GO categories of DEGs; (B–E) ADRB1 related pathways using the GSEA software. MF, molecular functions; BP, biological processes; CC, cellular components; GO, gene ontology; DEGs, differentially expressed genes.